Introduction	6.116343961237468
patients’	0.31828799847990075
novel	0.2790723122053909
drugs	0.23985662593088108
drugs	0.23985662593088108
drugs	0.23985662593088108
immune	0.23539409323488122
dysfunction	0.19192303076289408
microenvironment	0.19192303076289408
microenvironment	0.19192303076289408
Furthermore	0.13282082187747082
cell-mediated	0.16734729816984473
cells	0.15187726596882245
cells	0.15187726596882245
cells	0.15187726596882245
cells	0.15187726596882245
receptors’	0.3798476650515612
expression	0.34302866343645566
expression	0.34302866343645566
expression	0.34302866343645566
purposes	0.3381809983848945
Material	4.058171980618734
methods	3.397207933175053
collection	1.8856374475333901
collection	1.8856374475333901
collection	1.8856374475333901
sample	1.73648445520965
sample	1.73648445520965
samples	0.1929551672273132
HMAs	0.1751484060585189
HMAs	0.1751484060585189
patients	0.12511996309466838
patients	0.12511996309466838
Flow	2.1771271535054373
cytometry	1.6228054825979608
cytometry	1.6228054825979608
cytometry	1.6228054825979608
cytometry	1.6228054825979608
antibodies	0.22167886662250852
antibodies	0.22167886662250852
cytometry	0.20716665735293116
cytometry	0.20716665735293116
cytometry	0.20716665735293116
markers	0.16761221755852357
markers	0.16761221755852357
markers	0.16761221755852357
minutes	0.15814097691638818
minutes	0.15814097691638818
Statistical	2.765690730258156
analysis	1.6168504559378136
analysis	1.6168504559378136
analysis	1.6168504559378136
comparison	0.6469403601124971
T-test	0.4143792709653395
one-way	0.4143792709653395
ANOVA	0.368924725510794
GraphPad	0.368924725510794
Results	5.415904243096376
Patients’	3.765690730258156
characteristics	2.8284561713000853
characteristics	2.8284561713000853
characteristics	2.8284561713000853
characteristics	2.8284561713000853
variants	0.22934198644622564
Sophia	0.17200648983466924
Sophia	0.17200648983466924
patients	0.15226863433219076
patients	0.15226863433219076
consolidated	0.4558171980618735
allogeneic	0.4558171980618735
HSCT	0.4558171980618735
hematopoietic	0.4558171980618735
Eighteen	0.4558171980618735
modifies	2.279085990309367
subsets	1.486604739948789
subsets	1.486604739948789
subsets	1.486604739948789
plus	1.3023633414072375
cycle	0.29275158070791224
cycle	0.29275158070791224
cycle	0.29275158070791224
plus	0.2815920738177811
baseline	0.2375811848680856
induces	0.537955818608308
subsets	0.4247442114139397
subsets	0.4247442114139397
subsets	0.4247442114139397
plus	0.3721038118306393
alters	1.6232687922474938
plus	1.04189067312579
expression	0.8232687922474936
expression	0.8232687922474936
expression	0.8232687922474936
cycle	0.6499085091715652
cycle	0.6499085091715652
cycle	0.6499085091715652
plus	0.34729689104193
baseline	0.26045937304056793
cycle	0.7064222925777882
cycle	0.7064222925777882
cycle	0.7064222925777882
found	0.28444281254830434
found	0.28444281254830434
expression	0.4015945328036554
expression	0.4015945328036554
expression	0.4015945328036554
differences	0.2983582420115838
Tregs	0.28265443250488326
CD4+/CD8	0.911634396123747
modify	0.8116343961237469
Overall	0.7116343961237468
Overall	0.7116343961237468
indicate	0.6794415866350106
regulates	0.911634396123747
expression	0.8232687922474936
expression	0.8232687922474936
expression	0.8232687922474936
PD-1/TIM-3	0.8116343961237469
plus	0.3255908353518094
treated	0.2759940151935235
cycle	0.22566267679568233
cycle	0.22566267679568233
cycle	0.22566267679568233
cycle	0.2938862767571677
cycle	0.2938862767571677
cycle	0.2938862767571677
expression	0.25527714488294373
expression	0.25527714488294373
in-depth	0.2597028089833211
PD-1+/TIM-3	0.2597028089833211
induces	0.2597028089833211
Overall	0.24539117107715405
respect	0.24539117107715405
directed	0.7012572277874977
inquiries	0.7012572277874977
contributions	0.7012572277874977
original	0.6243341508644207
Material	0.6243341508644207
Introduction	6.116343961237468
ibrutinib	0.2342902022879347
ibrutinib	0.2342902022879347
treatment	0.229044167465532
treatment	0.229044167465532
treatment	0.229044167465532
ofatumumab	0.4641093887763566
ibrutinib	0.4431140782402243
ibrutinib	0.4431140782402243
combination	0.2354740975259294
combination	0.2354740975259294
Methods	5.946418959795156
months	0.18691664085000342
months	0.18691664085000342
months	0.18691664085000342
ofatumumab	0.1721696119654226
ibrutinib	0.16438102902459933
IWCLL	0.29343044651362254
IWCLL	0.29343044651362254
criteria	0.24540397602382902
criteria	0.24540397602382902
criteria	0.24540397602382902
intermediate	0.32558371290133814
onwards	0.32558371290133814
four-color	0.32558371290133814
Samples	0.28986942718705244
centrally	0.28986942718705244
details	0.450907997846526
CLL2-BIO	0.41841008113979505
Further	0.37746754813056144
Further	0.37746754813056144
page	0.33979688673541486
Harmonization-Good	0.4558171980618735
Conference	0.4558171980618735
authorities	0.4558171980618735
Practice	0.40581719806187344
Practice	0.40581719806187344
Results	5.415904243096376
induction	0.35686332003331045
predefined	0.2940756116528216
Between	0.2940756116528216
seizure	0.2940756116528216
summarized	0.26181754713669253
IGHV	0.6243341508644207
del(17p	0.6243341508644207
IGHV	0.6243341508644207
patients’	0.6243341508644207
unmutated	0.6243341508644207
rituximab	0.6243341508644207
rituximab	0.6243341508644207
therapies	0.47048799701826677
therapies	0.47048799701826677
patients	0.3448819495558167
dose	0.36348350624807885
dose	0.36348350624807885
patients	0.2527591200771489
patients	0.2527591200771489
patients	0.2527591200771489
patients	0.34012495714815033
patients	0.34012495714815033
patients	0.34012495714815033
patients	0.34012495714815033
patients	0.34012495714815033
bendamustine	0.3437569189745427
bendamustine	0.3437569189745427
bendamustine	0.3437569189745427
bendamustine	0.3437569189745427
debulking	0.33205205469367705
CR/CRi	0.34233552093255964
patients	0.3056908189244739
patients	0.3056908189244739
patients	0.3056908189244739
patients	0.3056908189244739
cohort	0.2538667908039206
cohort	0.2538667908039206
cohort	0.2538667908039206
among	0.21880523360871382
survival	0.20616889756980228
adverse	0.6134001335349581
events	0.5872667251550286
events	0.5872667251550286
events	0.5872667251550286
grade	0.3800595806734858
grade	0.6388849659928977
patients	0.40861962630917026
patients	0.40861962630917026
patients	0.40861962630917026
patients	0.40861962630917026
patients	0.5274665110853667
patients	0.5274665110853667
patients	0.5274665110853667
patients	0.5274665110853667
patients	0.5274665110853667
often	0.5474110739413437
among	0.3744935729072218
well	0.3582240263538593
skin/subcutaneous	0.35062861389374883
Cytopenias	0.35062861389374883
dysesthesia	1.0725110542632317
paresthesia	1.0725110542632317
abnormalities	0.5362555271316158
sensory	0.5362555271316158
debulking	0.3711170023046979
Introduction	6.116343961237468
cancer	0.57882815173655
cancer	0.57882815173655
cancer	0.57882815173655
epithelial	0.5064635534020816
ovarian	0.3303566088775086
resistance	0.36496208661936586
resistance	0.36496208661936586
deregulated	0.2940756116528216
mitochondria-mediated	0.2940756116528216
damage	0.2940756116528216
autophagy	0.39967152155000624
autophagy	0.39967152155000624
autophagy	0.39967152155000624
CSCs	0.2790723122053909
CSCs	0.2790723122053909
drugs	0.29595212715665165
drugs	0.29595212715665165
drugs	0.29595212715665165
CSCs	0.22955948262056347
CSCs	0.22955948262056347
animal	0.3388735219636889
effective	0.28316280760929313
effective	0.28316280760929313
188Re-liposome	0.2528090018657078
188Re-liposome	0.2528090018657078
188Re-liposome	0.3725606343284115
188Re-liposome	0.3725606343284115
188Re-liposome	0.3725606343284115
188Re-liposome	0.3725606343284115
188Re-liposome	0.3725606343284115
Results	5.415904243096376
Manufacture	3.0387813204124896
Administration	2.705447987079156
188Re-Liposome	2.2648052887833687
purity	0.2988965233192613
production	0.23332275282745799
production	0.23332275282745799
concentration	0.19496455605885757
concentration	0.19496455605885757
stage	0.9786150337979949
stage	0.9786150337979949
stage	0.9786150337979949
stages	0.7293075168989975
separately	0.6493075168989976
Model	1.1395429951546836
Accumulates	1.1395429951546836
Xenograft	1.1395429951546836
Delivery	1.0145429951546836
Intraperitoneal	1.0145429951546836
route	0.4774319977198511
route	0.4774319977198511
image	0.2681277635658079
delivery	0.2495696621735369
mice	0.2495696621735369
Targeting	1.5193906602062448
Mitophagy	1.5193906602062448
Autophagy	1.352723993539578
Vivo	1.1860573268729113
188Re-Liposome	1.1324026443916844
pattern	0.41860846830808635
indirect	0.2681277635658079
4′,6-diamidino-2-phenylindole	0.2681277635658079
nuclei	0.2681277635658079
localization	0.2681277635658079
lysosomal	0.46750481852499837
p21WAF/Cip1	0.46750481852499837
cycle	0.2777386791331475
cycle	0.2777386791331475
cycle	0.2777386791331475
autophagy	0.6176741696681914
autophagy	0.6176741696681914
autophagy	0.6176741696681914
188Re-liposome	0.48263536719816946
188Re-liposome	0.48263536719816946
Inhibit	0.7012572277874977
Able	0.7012572277874977
Growth	0.7012572277874977
Delivery	0.6243341508644207
Different	0.6243341508644207
routes	0.31828799847990075
188Re-liposome	0.3122934728929332
188Re-liposome	0.3122934728929332
188Re-liposome	0.3122934728929332
188Re-liposome	0.3122934728929332
Case	2.705447987079156
Presentation	2.705447987079156
Clinical	1.9314719554500352
pleural	0.2988965233192613
effusion	0.2988965233192613
effusion	0.2988965233192613
November	0.23332275282745799
chemotherapy	0.22276773332295433
October	0.4198108945467656
supraclavicular	0.3143566883185334
node	0.3143566883185334
lymph	0.27987392969784375
case	0.19980744366724504
cases	0.43542543070108747
cases	0.43542543070108747
expected	0.4205992692786576
expected	0.4205992692786576
expected	0.4205992692786576
Materials	4.058171980618734
Methods	2.973209479897578
Lines	2.029085990309367
Models	1.882845365129078
Animal	1.779085990309367
Cell	1.6986039665875265
line	0.23460474597486158
line	0.23460474597486158
cell	0.22707155731423997
penicillin	0.20035920793928505
sulfate	0.20035920793928505
intraperitoneal	0.2867036231830063
intraperitoneal	0.2867036231830063
mice	0.26516776605938297
mice	0.26516776605938297
ES2-luc	0.2536357487886709
mice	0.21147335860187552
mice	0.21147335860187552
188Re-BMEDA	0.1831228446873732
188Re-BMEDA	0.1831228446873732
188Re-BMEDA	0.1831228446873732
Taipei	0.7531381460516312
Taipei	0.7531381460516312
Taipei	0.7531381460516312
Taiwan	0.5648536095387234
Taiwan	0.5648536095387234
Preparation	3.0387813204124896
188Re-Liposome	2.2648052887833687
188Re-BMEDA	2.1771271535054373
188Re-BMEDA	2.1771271535054373
188Re-BMEDA	2.1771271535054373
liposome	0.43450277656824876
liposome	0.43450277656824876
water	0.35062861389374883
bath	0.35062861389374883
bath	0.35062861389374883
Blot	3.0387813204124896
Western	3.0387813204124896
Assay	2.705447987079156
PVDF	0.35062861389374883
Protein	0.35062861389374883
PVDF	0.35062861389374883
protein	0.22286214870577334
protein	0.22286214870577334
Abcam	1.5193906602062448
Abcam	1.5193906602062448
Danvers	0.7596953301031224
anti-p21Waf1/Cip1	0.7596953301031224
Anti-α-tubulin	0.7596953301031224
Morphology	1.823268792247494
Detect	1.823268792247494
Mitochondrial	1.823268792247494
Autophagy	1.6232687922474938
Analysis	1.2617978078359728
Olympus	0.4798075769072352
Olympus	0.4798075769072352
LC3B-GFP	0.42717599795986677
Valley	0.2399037884536176
BacMam	0.2399037884536176
Case	2.705447987079156
Presentation	2.705447987079156
Clinical	1.9314719554500352
cases	0.311018164786491
cases	0.311018164786491
dose	0.25790020205220837
dose	0.25790020205220837
188Re-liposome	0.2528090018657078
drug	0.6371652050701619
drug	0.6371652050701619
drug	0.6371652050701619
drug	0.6371652050701619
validating	0.5362555271316158
Analysis	3.154494519589932
Statistical	2.765690730258156
Survival	0.40581719806187344
Student’s	0.40581719806187344
t-test	0.40581719806187344
log-rank	0.40581719806187344
statistically	0.3397207933175053
Background	8.116343961237469
Despite	0.26658699838842087
Africa	0.24271097795082267
Africa	0.24271097795082267
South	0.23650677005510637
high	0.19007805480000695
AGYW	0.5259429208406232
AGYW	0.5259429208406232
incidence	0.3430626322958744
incidence	0.3430626322958744
incidence	0.3430626322958744
prevention	0.1872467864536109
prevention	0.1872467864536109
prevention	0.1872467864536109
went	0.17531430694687442
onward	0.17531430694687442
among	0.3140913837286376
young	0.3047759057070134
young	0.3047759057070134
people	0.2963085164632552
people	0.2963085164632552
people	0.2056469554558413
people	0.2056469554558413
people	0.2056469554558413
people	0.2056469554558413
community-based	0.20281838407015243
adolescents	0.5072714975773418
integrated	0.3381809983848945
psychosocial	0.27214089418817966
living	0.27214089418817966
progress	0.1899238325257806
peer-based	0.36465375844949877
interventions	0.34834034456087
interventions	0.34834034456087
amongst	0.27177663465400426
people	0.24494837360962432
peer-navigators	0.27212967048470055
peer-navigators	0.27212967048470055
Nami	0.22481735703033767
Thetha	0.22481735703033767
participatory	0.22481735703033767
prevention	0.3947364687400446
prevention	0.3947364687400446
prevention	0.3947364687400446
young	0.2553527858626329
young	0.2553527858626329
Objectives	9.116343961237469
Main	3.0387813204124896
objective	2.705447987079156
trial	1.0540492169501976
trial	1.0540492169501976
trial	1.0540492169501976
prevention	0.23748372916067723
prevention	0.23748372916067723
prevention	0.23748372916067723
trial	0.2313766573793117
trial	0.2313766573793117
Specific	3.0387813204124896
objectives	2.705447987079156
objectives	2.705447987079156
trial	1.0540492169501976
trial	1.0540492169501976
mobilisation	0.40581719806187344
decentralised	0.3765690730258156
prevention	0.36513123358454125
prevention	0.36513123358454125
prevention	0.36513123358454125
Methods	5.946418959795156
Trial	3.154494519589932
design	2.707952121548188
design	2.707952121548188
conducted	0.24275257824194527
conducted	0.24275257824194527
conducted	0.24275257824194527
assess	0.23326362358986827
intervention	0.2013638548188956
evaluation	0.36496208661936586
evaluation	0.36496208661936586
evaluation	0.36496208661936586
evaluation	0.36496208661936586
evaluation	0.36496208661936586
setting	4.058171980618734
setting	4.058171980618734
Study	2.765690730258156
clinics	0.17728533220978168
clinics	0.17728533220978168
clinics	0.17728533220978168
surveillance	0.17235996984913496
surveillance	0.17235996984913496
areas	0.5194056179666422
areas	0.5194056179666422
clusters	0.33575285846854364
clusters	0.33575285846854364
clusters	0.33575285846854364
Study	2.765690730258156
population	2.104726682814475
population	2.104726682814475
population	2.104726682814475
eligible	1.4142280856500427
eligible	1.4142280856500427
eligible	1.4142280856500427
receive	1.353976060774094
population	1.0523633414072375
based	0.34856780465510095
based	0.34856780465510095
residing	0.31216707543221034
pilot	0.31216707543221034
acquisition	0.28966851771216584
evaluation	1.8856374475333901
evaluation	1.8856374475333901
evaluation	1.8856374475333901
evaluation	1.8856374475333901
eligible	1.8856374475333901
period	0.6371652050701619
period	0.6371652050701619
period	0.6371652050701619
population-based	0.5362555271316158
16–30-year-olds	0.5362555271316158
interventions	3.265690730258156
interventions	3.265690730258156
Study	2.765690730258156
delayed	0.7116343961237468
delayed	0.7116343961237468
allocated	0.6794415866350106
receive	0.5415904243096377
rollout	0.4558171980618735
Standard	3.765690730258156
Care	3.558171980618734
counselling	0.32277349116498477
counselling	0.32277349116498477
prescription	0.2604669703210705
Individuals	0.23189554174964197
refills	0.2151823274433232
nawe	2.279085990309367
ngithethe	2.279085990309367
Thetha	1.882845365129078
Nami	1.882845365129078
2 weeks	0.27054479870791565
youth-friendly	0.27054479870791565
area-based	0.27054479870791565
mobilisation	0.27054479870791565
youth-friendly	0.27054479870791565
supervisors	0.21200799909854579
supervisors	0.21200799909854579
supervisors	0.21200799909854579
plans	0.14156413885879307
team	0.1347538573569792
procedures	2.038781320412489
procedures	2.038781320412489
mobile	1.982139653265052
clinic	1.8053014143654587
clinic	1.8053014143654587
offered	0.2117307120322818
counselling	0.1964708207091212
counselling	0.1964708207091212
negative	0.15512397286422147
negative	0.15512397286422147
PrEP/ART	0.31801199864781865
mobile	0.207433219527738
clinic	0.18892689220103637
clinic	0.18892689220103637
clinic	0.18892689220103637
Primary	3.265690730258156
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
transmissible	0.5387535564381114
transmissible	0.5387535564381114
co-primary	0.4341116172017842
averted	0.35863721240553864
averted	0.35863721240553864
acquire	0.40581719806187344
transmissible	0.28284561713000855
transmissible	0.28284561713000855
captures	0.22790859903093674
implies	0.22790859903093674
cost	0.3379815556703499
cost	0.3379815556703499
cost	0.3379815556703499
case	0.3104151356973271
case	0.3104151356973271
Secondary	3.397207933175053
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	0.29724972399575555
outcomes	0.29724972399575555
outcomes	0.29724972399575555
outcomes	0.29724972399575555
Secondary	0.28912407941915347
restriction	4.558171980618734
Randomisation	3.558171980618734
reasonably	0.21081412886331088
thresholds	0.21081412886331088
allocations	0.19562029767574837
randomisation	0.19562029767574837
restricted	0.19562029767574837
clusters	0.44840677808627866
clusters	0.44840677808627866
clusters	0.44840677808627866
clusters	0.44840677808627866
clusters	0.44840677808627866
Randomisation	2.3721146537458226
assignment	1.982139653265052
assignment	1.982139653265052
assignment	1.982139653265052
intervention	1.2529306522064614
ceremony	0.374644272379622
ceremony	0.374644272379622
four	0.25135660114674524
four	0.25135660114674524
sacks	0.24976284825308132
Blinding	9.116343961237469
Investigators	0.4558171980618735
masked	0.4558171980618735
statisticians	0.4558171980618735
blind	0.4558171980618735
teams	0.40581719806187344
discontinuing	1.823268792247494
modifying	1.6232687922474938
Criteria	1.3588831732700213
allocated	1.3588831732700213
interventions	1.3062762921032625
nurses	0.2940756116528216
PHCs	0.22955948262056347
clusters	0.1570456918643188
clusters	0.1570456918643188
clusters	0.1570456918643188
Strategies	1.6232687922474938
improve	1.3588831732700213
adherence	1.0831808486192753
adherence	1.0831808486192753
adherence	1.0831808486192753
reminders	0.4341116172017842
reminders	0.4341116172017842
support	0.24010403279099995
support	0.24010403279099995
support	0.24010403279099995
Outcome	4.558171980618734
ascertainment	4.058171980618734
process	0.2869723804962089
process	0.2869723804962089
process	0.2869723804962089
collected	0.2765591330398631
collected	0.2765591330398631
Cross-sectional	4.558171980618734
surveys	2.604726682814475
surveys	2.604726682814475
surveys	2.604726682814475
surveys	2.604726682814475
survey	0.453206381393403
survey	0.453206381393403
survey	0.453206381393403
survey	0.453206381393403
survey	0.453206381393403
enrol	0.3879295302654242
sampled	0.3453763387760625
written	0.2530391046721343
individuals	0.24071967415319875
individuals	0.24071967415319875
awareness	0.2463876746280397
contraception	0.19233362057398562
contraception	0.19233362057398562
contraception	0.19233362057398562
asked	0.17051321727513147
Programme	3.0387813204124896
process	1.7696630130599547
process	1.7696630130599547
process	1.7696630130599547
data	1.0313253827363378
collect	0.2635682948606469
PrEP	0.2299709798814899
PrEP	0.2299709798814899
PrEP	0.2299709798814899
PrEP	0.2299709798814899
Qualitative	3.558171980618734
data	1.5469880741045068
data	1.5469880741045068
data	1.5469880741045068
data	1.5469880741045068
assistants	0.3274513678485353
navigators	0.21864700521683167
navigators	0.21864700521683167
navigators	0.21864700521683167
research	0.2150616939041372
Costing	4.558171980618734
data	1.5469880741045068
data	1.5469880741045068
data	1.5469880741045068
data	1.5469880741045068
costs	0.4529610577566737
costs	0.4529610577566737
expenditure	0.4051708427216653
measure	0.25752959406000475
budgets	0.20258542136083266
Theory	3.765690730258156
change	2.558171980618734
change	2.558171980618734
prevention	0.3245610965195922
prevention	0.3245610965195922
prevention	0.3245610965195922
young	0.3149351025639139
young	0.3149351025639139
Sample	4.058171980618734
size	2.604726682814475
size	2.604726682814475
size	2.604726682814475
power	0.21569574178889225
power	0.21569574178889225
outcome	0.21297560816489253
outcome	0.21297560816489253
outcome	0.21297560816489253
management	2.654494519589932
management	2.654494519589932
Data	2.654494519589932
REDCap	0.6243341508644207
REDCap	0.6243341508644207
checks	0.46750481852499837
server	0.46750481852499837
Data	0.27225584816306997
Statistical	2.765690730258156
analysis	1.6168504559378136
analysis	1.6168504559378136
analysis	1.6168504559378136
factors	0.23785675839180623
survey	0.21235956156719457
survey	0.21235956156719457
survey	0.21235956156719457
survey	0.21235956156719457
programmatic	0.27987392969784375
survey	0.27460288133688954
survey	0.27460288133688954
survey	0.27460288133688954
survey	0.27460288133688954
PrEP	0.34074968360489055
PrEP	0.34074968360489055
PrEP	0.34074968360489055
PrEP	0.34074968360489055
PrEP	0.34074968360489055
reach	0.5364012526065873
reach	0.5364012526065873
reach	0.5364012526065873
packages	0.2399037884536176
equity	0.2399037884536176
multiplicity	0.33764236893472105
inferential	0.33764236893472105
otherwise	0.300605331897684
reflect	0.300605331897684
domains	0.300605331897684
In-depth	4.558171980618734
interviews	3.397207933175053
interviews	3.397207933175053
themes	0.4198108945467656
interview	0.3163626186846966
interview	0.3163626186846966
interview	0.3163626186846966
Interviews	0.3143566883185334
harms	2.029085990309367
event	1.882845365129078
Adverse	1.6986039665875265
reporting	1.4142280856500427
reporting	1.4142280856500427
SAEs	0.256798421443309
community	0.17229137918978785
Committee	0.17229137918978785
Committee	0.17229137918978785
community	0.17229137918978785
oversight	2.705447987079156
Ethics	2.1771271535054373
trial	1.0540492169501976
trial	1.0540492169501976
trial	1.0540492169501976
study	0.14955899641664702
study	0.14955899641664702
study	0.14955899641664702
study	0.14955899641664702
study	0.14955899641664702
Availability	3.0387813204124896
materials	2.705447987079156
materials	2.705447987079156
data	1.0313253827363378
data	1.0313253827363378
datasets	0.6837257970928102
available	0.3265690730258156
generated	0.3154494519589932
study	0.23892049677559368
study	0.23892049677559368
Declarations	9.116343961237469
Ethics	1.632845365129078
participate	1.577247259794966
participate	1.577247259794966
approval	1.577247259794966
approval	1.577247259794966
study	0.14955899641664702
study	0.14955899641664702
study	0.14955899641664702
study	0.14955899641664702
study	0.14955899641664702
Consent	4.058171980618734
publication	3.765690730258156
applicable	8.116343961237469
applicable	8.116343961237469
Background	8.116343961237469
options	0.296939413216005
Sorafenib	0.222349852713109
Sorafenib	0.222349852713109
tumor	0.16802860994562646
advanced	0.15930198684186128
antigens	0.4021916453487118
vaccination	0.3322668291404255
vaccination	0.3322668291404255
peptides	0.2681277635658079
telomerase	0.23871599885992556
vaccine	0.39591921762133997
regulatory	0.31860397368372256
effect	0.31529188091559984
effect	0.31529188091559984
effect	0.31529188091559984
Methods	5.946418959795156
Patient	2.973209479897578
population	2.104726682814475
population	2.104726682814475
population	2.104726682814475
liter	0.1899238325257806
liter	0.1899238325257806
liter	0.1899238325257806
liter	0.1899238325257806
deciliter	0.14244287439433545
Plan	4.558171980618734
Treatment	3.765690730258156
illness	0.3315034167722716
concurrent	0.3315034167722716
illness	0.3315034167722716
Criteria	0.24706966786727658
Adverse	0.24706966786727658
Delayed	2.279085990309367
hypersensitivity	2.029085990309367
type	1.632845365129078
type	1.632845365129078
analysis	0.8084252279689068
skin	1.2431378128960184
reaction	1.0270065627976788
reaction	1.0270065627976788
hours	0.6846710418651193
hours	0.6846710418651193
vitro	1.6986039665875265
vitro	1.6986039665875265
responses	1.279085990309367
responses	1.279085990309367
immune	1.118121942865686
clone	0.3879295302654242
Germany	0.22711736046502556
Germany	0.22711736046502556
Germany	0.22711736046502556
Germany	0.22711736046502556
Statistical	2.765690730258156
analysis	1.6168504559378136
analysis	1.6168504559378136
analysis	1.6168504559378136
symptomatic	0.25530106645818007
TTSP	0.20634772782807126
TTSP	0.20634772782807126
progression	0.19642087682542733
date	0.17273938643262984
Results	5.415904243096376
Characteristics	4.058171980618734
patients	1.3450396032676852
patients	1.3450396032676852
patients	1.3450396032676852
patients	1.3450396032676852
patients	0.46559063190035255
patients	0.46559063190035255
patients	0.46559063190035255
patients	0.46559063190035255
patients	0.46559063190035255
conduct	2.5104604868387703
Clinical	1.9314719554500352
trial	1.0540492169501976
trial	1.0540492169501976
trial	1.0540492169501976
months	0.66858644611732
months	0.66858644611732
months	0.66858644611732
patients	0.46559063190035255
patients	0.46559063190035255
Safety	4.558171980618734
events	2.707952121548188
events	2.707952121548188
events	2.707952121548188
events	0.532711892763578
events	0.532711892763578
events	0.532711892763578
Grade	0.4483447849788919
Grade	0.4483447849788919
Efficacy	9.116343961237469
patients	0.29010658109695164
patients	0.29010658109695164
patients	0.29010658109695164
patients	0.29010658109695164
patients	0.29010658109695164
Immune	2.705447987079156
response	1.4031511218763166
response	1.4031511218763166
response	1.4031511218763166
analysis	1.0779003039585424
immunization	0.2463876746280397
CD4+CD25+Foxp3	0.2463876746280397
immunization	0.2463876746280397
responses	0.20741934977989737
responses	0.20741934977989737
Introduction	6.116343961237468
immune	0.2662195102061157
immunity	0.2170558086008921
evasion	0.2170558086008921
programmed	0.17931860620276932
anti-tumor	0.15021402474237772
immunotherapy	0.19233362057398562
immunotherapy	0.19233362057398562
checkpoints	0.14624043173400844
checkpoints	0.14624043173400844
MHC-II	0.13570056685614976
tumor	0.3145741099438668
nivolumab	0.24976284825308132
alone	0.19496832770513609
alone	0.19496832770513609
alone	0.19496832770513609
monotherapy	0.20905894973384942
monotherapy	0.20905894973384942
mouse	0.18296673722446635
activity	0.1666432074798885
activity	0.1666432074798885
single-domain	0.32558371290133814
immunomodulatory	0.32558371290133814
anti-PD-L1/LAG-3	0.32558371290133814
bispecific	0.28986942718705244
bridging	0.28986942718705244
Materials	4.058171980618734
methods	3.397207933175053
Reagents	9.116343961237469
China	0.7907048845819409
China	0.7907048845819409
China	0.7907048845819409
purchased	0.7549350962611229
Shanghai	0.6752847378694421
Antibody	3.0387813204124896
purification	2.705447987079156
generation	2.705447987079156
purification	2.705447987079156
affinity	0.36970083738771575
affinity	0.36970083738771575
clones	0.30627713061273465
clones	0.30627713061273465
screening	0.24646722492514384
sdAb	0.6752847378694421
phage-display	0.33764236893472105
camel	0.33764236893472105
immunized	0.33764236893472105
library	0.33764236893472105
fragments	1.0145429951546836
polished	1.0145429951546836
resin	0.941422682564539
resin	0.941422682564539
produced	0.8895429951546835
Mice	6.116343961237468
mice	0.377127489506678
mice	0.377127489506678
strain	0.30387813204124897
extracellular	0.27054479870791565
exon	0.27054479870791565
kinetics	1.5193906602062448
plasma	1.5193906602062448
Surface	1.5193906602062448
antibody-binding	1.5193906602062448
resonance	1.2552302434193852
Healthcare	0.48893638320707644
Healthcare	0.48893638320707644
sensor	0.48893638320707644
running	0.2933618299242459
dissociation	0.21967093882499927
IBI323-antigen	1.823268792247494
interactions	1.823268792247494
Bio-layer	1.823268792247494
interferometry	1.6232687922474938
analysis	0.6467401823751255
sensor	0.601210663795368
solution	0.4673325214207307
solution	0.4673325214207307
streptavidin	0.33764236893472105
biolayer	0.33764236893472105
construction	3.0387813204124896
line	2.3721146537458226
line	2.3721146537458226
Cell	2.2648052887833687
transfected	0.42401599819709157
human	0.41604537408955755
Invitrogen	0.3775043702901148
Invitrogen	0.3775043702901148
express	0.33099274238313803
Cell-based	3.0387813204124896
assay	2.3721146537458226
assay	2.3721146537458226
binding	1.9314719554500352
cells	0.2753662579247809
cells	0.2753662579247809
cells	0.2753662579247809
cells	0.2753662579247809
cells	0.2753662579247809
Blocking	4.558171980618734
assays	3.558171980618734
assays	3.558171980618734
washed	0.49648911357470704
Biosystems	0.33099274238313803
China	0.33099274238313803
Acro	0.33099274238313803
Biosystems	0.33099274238313803
washed	0.3471387298164619
concentration	0.2900692175509832
concentration	0.2900692175509832
LAG3-mouse	0.222349852713109
3 μg/mL	0.222349852713109
Luciferase	3.0387813204124896
assays	2.3721146537458226
assays	2.3721146537458226
reporter	2.3721146537458226
cells	0.3535702751754187
cells	0.3535702751754187
cells	0.3535702751754187
cells	0.3535702751754187
cells	0.3535702751754187
Promega	0.27987392969784375
density	0.2597028089833211
cells	0.25400163446509966
cells	0.25400163446509966
cells	0.25400163446509966
Crosslinking	3.0387813204124896
PD-L1+ cells	2.5104604868387703
LAG-3+ cells	2.5104604868387703
LAG-3+ cells	2.5104604868387703
Scientific	0.4853154190250076
Scientific	0.4853154190250076
Scientific	0.4853154190250076
Scientific	0.4853154190250076
Scientific	0.4853154190250076
MDA-MB-231	0.59387882643201
cells	0.5030471394772217
cells	0.5030471394772217
cells	0.5030471394772217
cells	0.5030471394772217
Mixed	3.0387813204124896
reactions	2.3721146537458226
reactions	2.3721146537458226
lymphocyte	2.102996346393288
concentration	0.3964279306530104
concentration	0.3964279306530104
five-fold	0.30387813204124897
0.1 ng/mL	0.30387813204124897
Toxin	0.30387813204124897
Tumor	3.397207933175053
models	2.707952121548188
models	2.707952121548188
models	2.707952121548188
MC38-hPD-L1	1.3023348516053526
PD-L1/LAG-3	1.0166205658910668
knock-in	0.9706308380500152
mice	0.8081303346571672
mice	0.8081303346571672
mg/kg	0.54387836544654
mg/kg	0.54387836544654
mg/kg	0.54387836544654
mg/kg	0.54387836544654
volume	0.5194056179666422
humanized	1.6986039665875265
mice	1.4142280856500427
mice	1.4142280856500427
tumor	1.148195501295114
model	1.103976060774094
mg/kg	0.5735444581072604
mg/kg	0.5735444581072604
mg/kg	0.5735444581072604
mg/kg	0.5735444581072604
tumor	0.4175256368345869
mg/kg	1.2617978078359728
mg/kg	1.2617978078359728
mg/kg	1.2617978078359728
mg/kg	1.2617978078359728
well-established	0.23189554174964197
tumor-infiltrating	1.6232687922474938
Flow	1.3062762921032625
cytometry	0.9736832895587766
cytometry	0.9736832895587766
cytometry	0.9736832895587766
anti-mouse	0.8935537326036301
BioLegend	0.7659031993745401
BioLegend	0.7659031993745401
BioLegend	0.7659031993745401
BioLegend	0.7659031993745401
Statistical	2.765690730258156
analyses	2.397207933175053
analyses	2.397207933175053
analyses	2.397207933175053
analyses	2.397207933175053
GraphPad	0.6493075168989976
GraphPad	0.6493075168989976
mean	0.4023104895989703
mean	0.4023104895989703
p-value	0.36465375844949877
Results	5.415904243096376
Generation	2.279085990309367
BsAb	2.029085990309367
targeting	1.529085990309367
targeting	1.529085990309367
human	1.118121942865686
Fc-mediated	0.3090286088555074
LALA	0.27513030377076164
LALA	0.27513030377076164
reduced	0.17047054644024165
reduced	0.17047054644024165
properties	3.0387813204124896
Binding	2.705447987079156
blocking	1.8437938201721038
blocking	1.8437938201721038
affinity	0.6320691735983528
affinity	0.6320691735983528
binding	0.5607499225500102
Figure	0.34768858114649565
Figure	0.34768858114649565
expressing	0.4529610577566737
cells	0.3928558613060208
cells	0.3928558613060208
cells	0.3928558613060208
cells	0.3928558613060208
cells	0.3683023699743945
cells	0.3683023699743945
cells	0.3683023699743945
cells	0.3683023699743945
cells	0.3683023699743945
axes	1.6232687922474938
induces	1.5062762921032624
T-cell	1.2617978078359728
activation	1.1062762921032625
blocking	1.1062762921032625
completely	0.3879295302654242
blocking	0.3530669017350837
blocking	0.3530669017350837
block	0.28912407941915347
block	0.28912407941915347
Jurkat	0.3454787728652597
PD-1/PD-L1	0.25530106645818007
PD-1/PD-L1	0.25530106645818007
blockade	0.25530106645818007
cells	0.2496965220165386
PD-L1+ APCs	1.1594777087482098
LAG-3 + T	1.1594777087482098
enhances	1.075911637216616
crosslinking	1.075911637216616
activation	0.7901973515023302
complexes	0.3598556826804264
proportion	0.25781768923090703
concentration	0.23472706420244036
concentration	0.23472706420244036
molecules	0.18727220950624915
cells	0.5357125381445739
cells	0.5357125381445739
cells	0.5357125381445739
cells	0.5357125381445739
cells	0.5357125381445739
secretion	0.32347018005624856
IFN-γ	0.2968809754780142
stabilizing	0.20718963548266975
mediating	0.20718963548266975
mixing	0.20718963548266975
Anti-tumor	1.6232687922474938
humanized	1.3588831732700213
mouse	1.1892837919590311
efficacy	1.0831808486192753
models	1.0831808486192753
mice	0.24330805774624392
mice	0.24330805774624392
inhibited	0.22955948262056347
knock-in	0.21917470536613246
growth	0.21068972453278426
doses	0.39535244229097044
doses	0.39535244229097044
mg/kg	0.350499391065548
mg/kg	0.350499391065548
mg/kg	0.350499391065548
anti-PD-L1	0.30940625918423775
tumor	0.299529261207421
tumors	0.2585399547737024
tumors	0.2585399547737024
quite	0.1981813904616841
Increase	1.3023348516053526
extra-tumoral	1.3023348516053526
intra	1.3023348516053526
tumor-specific	1.075911637216616
cells	0.8418339885129016
tumor	0.2213388918159256
number	0.1849280949844868
number	0.1849280949844868
number	0.1849280949844868
post-tumor	0.18147907133774246
Introduction	6.116343961237468
transplant	0.22236558797910871
transplant	0.22236558797910871
settings	0.1789419578223647
settings	0.1789419578223647
settings	0.1789419578223647
beneficial	0.4798075769072352
associated	0.25623244462073064
Teffs	0.2399037884536176
immunosuppression	0.2399037884536176
Low-dose	0.2399037884536176
immunophenotyping	0.22790859903093674
epigenomic	0.22790859903093674
genomic	0.22790859903093674
transcriptomic	0.22790859903093674
predictive	0.20290859903093672
Results	5.415904243096376
definition	1.1324026443916844
definition	1.1324026443916844
definition	1.1324026443916844
Trial	1.051498173196644
therapeutic	0.9428187237666951
pediatric	0.2681277635658079
material	0.2681277635658079
supplemental	0.2681277635658079
https://doi.org/10.1172/jci.insight.161812DS1	0.2681277635658079
Eighty-eight	0.2681277635658079
C-peptide	0.7279602737515228
placebo	0.33429322305866
placebo	0.33429322305866
placebo	0.33429322305866
placebo	0.33429322305866
slope	0.49691901803494704
slope	0.49691901803494704
responders	0.3132455486471919
responders	0.3132455486471919
responders	0.3132455486471919
Treatment	3.765690730258156
effects	2.3284561713000853
effects	2.3284561713000853
effects	2.3284561713000853
effects	2.3284561713000853
Transient	1.352723993539578
lymphocyte	1.051498173196644
low-dose	1.0193906602062446
administration	1.0193906602062446
administration	1.0193906602062446
count	0.4066256748315864
count	0.4066256748315864
count	0.4066256748315864
premedication	0.3198717179381568
premedication	0.3198717179381568
distinguishes	1.0129271068041632
Differential	0.901815995693052
pattern	0.7907048845819409
neutrophil	0.700998782131096
neutrophil	0.700998782131096
enrichment	0.21830091189902354
neutrophil	0.18286924751245984
neutrophil	0.18286924751245984
gene	0.14829982496340488
gene	0.14829982496340488
gene	0.2882447302105616
gene	0.2882447302105616
gene	0.2882447302105616
BH-adjusted	0.2121515904370792
BH-adjusted	0.2121515904370792
surge	2.705447987079156
cytokine	2.1771271535054373
cytokine	2.1771271535054373
induced	2.038781320412489
innate	0.23079351800601186
sIL-2RA	0.20547706230980933
sIL-2RA	0.20547706230980933
weeks	0.18206642530443443
weeks	0.18206642530443443
cells	0.34663752468178305
cells	0.34663752468178305
cells	0.34663752468178305
cells	0.34663752468178305
cells	0.34663752468178305
adhesion	1.1594777087482098
trafficking	1.075911637216616
Teff	1.0166205658910668
Teff	1.0166205658910668
markers	0.8081303346571672
cytometric	0.32558371290133814
corroborate	0.32558371290133814
covering	0.32558371290133814
epigenetic	0.28986942718705244
persistent	0.28986942718705244
weeks	0.21792799392500484
weeks	0.21792799392500484
weeks	0.21792799392500484
weeks	0.21792799392500484
weeks	0.21792799392500484
adhesion	0.2766935441330955
trafficking	0.2567516406994197
expression	0.23388317961576524
expression	0.23388317961576524
expression	0.23388317961576524
unchanged	1.075911637216616
unchanged	1.075911637216616
bulk	1.0166205658910668
PBMCs	0.9706308380500152
PBMCs	0.9706308380500152
FOXP3	0.29651433171822783
FOXP3	0.29651433171822783
FOXP3	0.29651433171822783
Tregs	0.2414339944312544
Tregs	0.2414339944312544
locus	0.26424185394891214
Supplemental	0.24049484610940486
Supplemental	0.24049484610940486
transcription	0.21830091189902354
transcription	0.21830091189902354
Response	3.765690730258156
effects	2.3284561713000853
effects	2.3284561713000853
effects	2.3284561713000853
effects	2.3284561713000853
Baseline	1.6986039665875265
therapeutic	1.4142280856500427
characteristics	1.4142280856500427
characteristics	1.4142280856500427
characteristics	1.4142280856500427
responders	0.2558171980618734
responders	0.2558171980618734
responders	0.2558171980618734
responders	0.2558171980618734
responders	0.2558171980618734
profiles	1.6232687922474938
Baseline	1.3588831732700213
therapeutic	1.1313824685200342
responders	1.0232687922474937
responders	1.0232687922474937
percentage	0.26488745926926865
percentage	0.26488745926926865
percentage	0.26488745926926865
intron	0.25530106645818007
intron	0.25530106645818007
Posttreatment	1.823268792247494
profiles	1.6232687922474938
therapeutic	1.1313824685200342
responders	1.0232687922474937
responders	1.0232687922474937
week	0.40724366710850934
week	0.40724366710850934
week	0.40724366710850934
week	0.40724366710850934
responders	0.3528513076715495
nonresponders	0.2977322285579037
nonresponders	0.2977322285579037
nonresponders	0.2977322285579037
nonresponders	0.2977322285579037
responders	0.26928126111776146
phenotype	0.497152380464642
phenotype	0.497152380464642
phenotype	0.497152380464642
senescence	0.444699705426218
senescence	0.444699705426218
responders	0.5949237164229614
responders	0.5949237164229614
responders	0.5949237164229614
responders	0.5949237164229614
responders	0.5949237164229614
Together	0.676361996769789
modalities	0.5930286634364557
signature	0.5930286634364557
modalities	0.5930286634364557
exhaustion	0.5662013221958422
immunologic	1.5193906602062448
multimodal	1.5193906602062448
prediction	1.2552302434193852
prediction	1.2552302434193852
Exploratory	1.2552302434193852
variables	0.24243910039715016
variables	0.24243910039715016
variables	0.24243910039715016
Supplemental	0.19754933787558254
Supplemental	0.19754933787558254
Methods	5.946418959795156
Clinical	2.897207933175053
trial	1.5810738254252965
trial	1.5810738254252965
trial	1.5810738254252965
trial	1.5810738254252965
participants	0.2882874380105758
participants	0.2882874380105758
participants	0.2882874380105758
participants	0.2882874380105758
low-dose	0.19113574878867087
isolation	4.558171980618734
gDNA	3.558171980618734
gDNA	3.558171980618734
QiaCube	0.5064635534020816
nucleic	0.5064635534020816
Qiagen	0.5064635534020816
Mini	0.5064635534020816
acid	0.5064635534020816
Genetic	4.558171980618734
analysis	1.6168504559378136
analysis	1.6168504559378136
analysis	1.6168504559378136
genotype	0.4798075769072352
non-HLA	0.4798075769072352
custom	0.4798075769072352
Axiom	0.4798075769072352
HLA-DR-DQ	0.4798075769072352
history	4.558171980618734
infectious	4.558171980618734
EBNA	0.889399410852436
EBNA	0.889399410852436
infection	0.5967164840231676
antigen	0.3471387298164619
antigen	0.3471387298164619
Cytokine/chemokine	4.558171980618734
studies	2.296391002590228
studies	2.296391002590228
studies	2.296391002590228
pg/mL	0.33764236893472105
pg/mL	0.33764236893472105
concentrations	0.2635682948606469
concentrations	0.2635682948606469
instructions	0.251645032087041
methylation	2.707952121548188
methylation	2.707952121548188
studies	2.296391002590228
studies	2.296391002590228
studies	2.296391002590228
sites	0.2163826709028696
chromosome	0.20678583340732407
methylation	0.17248102685020306
methylation	0.17248102685020306
gene	0.1629408904852697
Flow	3.265690730258156
cytometry	2.4342082238969414
cytometry	2.4342082238969414
cytometry	2.4342082238969414
cytometry	2.4342082238969414
panels	0.1585451123693473
panels	0.1585451123693473
technical	0.1411538080215212
acquisition	0.13098054713941412
fewer	0.11816375419739315
Transcriptomic	4.558171980618734
analysis	1.6168504559378136
analysis	1.6168504559378136
analysis	1.6168504559378136
libraries	0.2826773321313944
libraries	0.2826773321313944
libraries	0.2826773321313944
Illumina	0.2516695801934099
Illumina	0.2516695801934099
Responder	2.279085990309367
multivariable	1.882845365129078
modeling	1.779085990309367
modeling	1.779085990309367
modeling	1.779085990309367
slope	0.601210663795368
slope	0.601210663795368
C-peptide	0.4673325214207307
nonresponders	0.4190305438963089
nonresponders	0.4190305438963089
count	0.2414339944312544
count	0.2414339944312544
count	0.2414339944312544
absolute	0.2414339944312544
assessment	0.18142726279211976
variables	0.5012453974455847
variables	0.5012453974455847
variables	0.5012453974455847
selected	0.3096883018348085
selected	0.3096883018348085
values	0.33979536913115177
values	0.33979536913115177
values	0.33979536913115177
variables	0.3232521338628669
variables	0.3232521338628669
Statistics	9.116343961237469
method	0.22822368062170642
method	0.22822368062170642
method	0.22822368062170642
variable	0.19118148603575347
variable	0.19118148603575347
genes	0.33275954956471593
genes	0.33275954956471593
genes	0.33275954956471593
genes	0.33275954956471593
genes	0.33275954956471593
package	0.9488458614983291
package	0.9488458614983291
using	0.6467401823751255
using	0.6467401823751255
emmeans	0.6077562640824979
approval	3.154494519589932
approval	3.154494519589932
approval	3.154494519589932
Study	2.765690730258156
samples	0.46094845504302595
minors	0.3798476650515612
deidentified	0.3798476650515612
representative	0.3798476650515612
fashion	0.3381809983848945
availability	4.058171980618734
availability	4.058171980618734
Data	2.654494519589932
Supporting	0.6287133766370668
available	0.45044010072526286
Data	0.3661371751158527
website	0.3143566883185334
Resources	0.3143566883185334
Introduction	6.116343961237468
loading	0.32753331597260366
clopidogrel	0.1704513523649693
clopidogrel	0.1704513523649693
dose	0.1621528216495921
dose	0.1621528216495921
clopidogrel	0.41860846830808635
clopidogrel	0.41860846830808635
periprocedural	0.39967152155000624
complications	0.3597849388963216
complications	0.3597849388963216
clopidogrel	0.6469403601124971
clopidogrel	0.6469403601124971
‘selective’	0.2762528473102263
really	0.2762528473102263
CAG/a	0.2762528473102263
Methods	5.946418959795156
institutions	0.4798075769072352
registration	0.42717599795986677
ethical	0.3963884979219111
committees	0.3963884979219111
report	0.3963884979219111
arms	2.038781320412489
arms	2.038781320412489
arms	2.038781320412489
Patients	1.705447987079156
treatment	0.8856374475333904
elective	0.29534829256926715
patients	0.2109866044341467
patients	0.2109866044341467
patients	0.2109866044341467
patients	0.2109866044341467
clopidogrel	0.35142439314752927
clopidogrel	0.35142439314752927
group	0.2893993033784088
group	0.2893993033784088
group	0.2893993033784088
Invasive	4.558171980618734
procedures	3.058171980618734
procedures	3.058171980618734
procedures	0.2073336936012701
procedures	0.2073336936012701
disease	0.16013649282910875
disease	0.16013649282910875
disease	0.16013649282910875
Examinations	4.558171980618734
follow-up	3.397207933175053
follow-up	3.397207933175053
CK-MB	0.3864925695827366
CK-MB	0.3864925695827366
troponin	0.3388735219636889
done	0.3388735219636889
done	0.3388735219636889
Endpoints	7.531381460516312
endpoint	0.4254908815781779
endpoint	0.4254908815781779
endpoint	0.4254908815781779
endpoint	0.4254908815781779
attack/re-intervention	0.35062861389374883
non-vascular	1.5193906602062448
cardiovascular	1.5193906602062448
Death	1.352723993539578
mortality	1.0885635767527186
mortality	1.0885635767527186
persisting	0.3879295302654242
defined	0.3856494860013882
defined	0.3856494860013882
defined	0.3856494860013882
ischaemic	0.28912407941915347
bleeding	0.6447924173271855
bleeding	0.6447924173271855
bleeding	0.6447924173271855
haemoglobin	0.2933618299242459
major	0.2360740286933607
methods	3.397207933175053
Statistical	2.765690730258156
group	0.20781332955364462
group	0.20781332955364462
group	0.20781332955364462
group	0.20781332955364462
group	0.20781332955364462
indicator	0.35062861389374883
linearity	0.35062861389374883
assumption	0.31216707543221034
logit	0.31216707543221034
continuous	0.24265342458384095
Stata	1.657517083861358
Stata	1.657517083861358
Station	0.828758541930679
Corp	0.828758541930679
College	0.828758541930679
Results	5.415904243096376
Revascularizations	9.116343961237469
non-significant	0.30387813204124897
angiogram	0.30387813204124897
lesions	0.30387813204124897
stenosis	0.30387813204124897
vessel	0.30387813204124897
Endpoints	1.882845365129078
among	1.2171041119484707
study	0.7964016559186455
study	0.7964016559186455
study	0.7964016559186455
group	0.5123790945060352
group	0.5123790945060352
group	0.5123790945060352
group	0.5123790945060352
group	0.5123790945060352
percutaneous	1.1594777087482098
Endpoints	1.075911637216616
coronary	0.9330544943594731
underwent	0.873763423033924
among	0.6954880639705546
group	1.3472036536581102
group	1.3472036536581102
group	1.3472036536581102
group	1.3472036536581102
group	1.3472036536581102
graft	1.352723993539578
bypass	1.2552302434193852
artery	1.2552302434193852
coronary	1.0885635767527186
underwent	1.0193906602062446
CABG	0.7257090511684791
CABG	0.7257090511684791
CABG	0.7257090511684791
bleeding	0.44047547850334484
bleeding	0.44047547850334484
Strengths	3.0387813204124896
limitations	3.0387813204124896
study	1.061868874558194
study	1.061868874558194
study	1.061868874558194
protocolized	0.42717599795986677
post-extubation	0.42717599795986677
pragmatic	0.3963884979219111
pragmatic	0.3963884979219111
comparison	0.3745444190124983
moderately	0.7012572277874977
opportunity	0.7012572277874977
subgroups	0.6243341508644207
examine	0.6243341508644207
subgroups	0.6243341508644207
centre	2.029085990309367
single	1.529085990309367
single	1.529085990309367
conducted	1.132845365129078
conducted	1.132845365129078
blinding	1.823268792247494
nature	1.5062762921032624
allow	1.3588831732700213
intervention	0.751758391323877
intervention	0.751758391323877
Decisions	0.911634396123747
deferred	0.8116343961237469
regarding	0.6116343961237468
team	0.5794415866350107
team	0.5794415866350107
Introduction	6.116343961237468
ventilation	0.27149577807233954
ventilation	0.27149577807233954
ventilation	0.27149577807233954
ventilation	0.27149577807233954
ventilation	0.27149577807233954
failure	0.333286414959777
failure	0.333286414959777
failure	0.333286414959777
extubation	0.3166418431721129
extubation	0.3166418431721129
congestive	0.19192303076289408
reintubation	0.18831527458790498
reintubation	0.18831527458790498
postextubation	0.18831527458790498
reintubation	0.18831527458790498
HFNC	0.2475650303824581
HFNC	0.2475650303824581
HFNC	0.2475650303824581
HFNC	0.2475650303824581
patients	0.21694187149478794
studies	0.21870390500859313
studies	0.21870390500859313
studies	0.21870390500859313
form	0.1941696495630942
form	0.1941696495630942
adults	0.21414365444315778
adults	0.21414365444315778
critically	0.21414365444315778
support	0.16531753077413114
support	0.16531753077413114
Methods	2.973209479897578
analysis	1.6168504559378136
analysis	1.6168504559378136
analysis	1.6168504559378136
SPIRIT	1.0129271068041632
SPIRIT	1.0129271068041632
Interventional	0.5064635534020816
Items	0.5064635534020816
Protocol	0.5064635534020816
Study	2.765690730258156
design	2.707952121548188
design	2.707952121548188
pragmatic	0.22481735703033767
pragmatic	0.22481735703033767
protocolised	0.150115854327974
protocolised	0.150115854327974
compares	0.13606483524235027
public	2.2648052887833687
involvement	2.2648052887833687
Patient	1.982139653265052
public	0.9706308380500152
disseminated	0.6511674258026763
completion	0.5797388543741049
question	0.5797388543741049
identifying	0.537955818608308
site	2.2648052887833687
site	2.2648052887833687
site	2.2648052887833687
Study	1.8437938201721038
population	1.4031511218763166
Center	1.1594777087482098
Vanderbilt	1.1594777087482098
Center	1.1594777087482098
Medical	0.9012841484542663
University	0.9012841484542663
located	2.279085990309367
unit	1.529085990309367
unit	1.529085990309367
unit	1.529085990309367
unit	1.529085990309367
Patient	1.1892837919590311
undergoing	1.1588831732700213
mechanical	0.9892837919590312
ventilation	0.9448053076917416
ventilation	0.9448053076917416
12 hours	1.5193906602062448
receiving	1.051498173196644
Patient	0.991069826632526
least	0.8848315065299773
least	0.8848315065299773
years	5.656912342600171
years	5.656912342600171
years	5.656912342600171
years	5.656912342600171
inclusion	3.265690730258156
criteria	2.362013269229354
criteria	2.362013269229354
criteria	2.362013269229354
criteria	2.362013269229354
tracheostomy	2.029085990309367
tracheostomy	2.029085990309367
receiving	1.577247259794966
Patient	1.486604739948789
ventilation	1.181006634614677
Reintubate’	1.0129271068041632
order	0.901815995693052
place	0.8368201622795901
comfort	0.7907048845819409
extubated	0.7257090511684791
attempt	1.3023348516053526
hospitalisation	1.1594777087482098
hospitalisation	1.1594777087482098
required	0.9012841484542663
Patient	0.8494884228278794
Unplanned	1.1395429951546836
self-extubation	1.0145429951546836
deemed	1.0145429951546836
self-extubation	1.0145429951546836
necessary	0.8895429951546835
exclusion	2.705447987079156
criteria	1.5746755128195693
criteria	1.5746755128195693
criteria	1.5746755128195693
criteria	1.5746755128195693
diagram	0.46750481852499837
number	0.39356492009518984
number	0.39356492009518984
number	0.39356492009518984
template	0.23375240926249918
Randomisation	2.3721146537458226
allocation	2.3721146537458226
treatment	0.8856374475333904
treatment	0.8856374475333904
treatment	0.8856374475333904
hallway	0.3227024411057511
hallway	0.3227024411057511
cluster	0.18110952075176878
cluster	0.18110952075176878
cluster	0.18110952075176878
respiratory	0.32218216771023295
respiratory	0.32218216771023295
therapist	0.27991634830784196
therapist	0.27991634830784196
assigned	0.27991634830784196
interventions	3.265690730258156
interventions	3.265690730258156
Study	2.765690730258156
Protocolised	4.558171980618734
support	1.6807282295369999
support	1.6807282295369999
support	1.6807282295369999
support	1.6807282295369999
respiratory	0.4337067642253136
respiratory	0.4337067642253136
support	0.3878603606623846
support	0.3878603606623846
support	0.3878603606623846
minute	0.2728182844113435
minute	0.2728182844113435
minute	0.2728182844113435
cmH2O	0.22982379734212108
cmH2O	0.22982379734212108
HFNC	0.3148519360761519
HFNC	0.3148519360761519
HFNC	0.3148519360761519
HFNC	0.3148519360761519
surgery	0.23173481416973268
minute	0.4774319977198511
minute	0.4774319977198511
minute	0.4774319977198511
titration	0.41860846830808635
flow	0.25975907312331625
extubation	0.4116343961237468
extubation	0.4116343961237468
extubation	0.4116343961237468
extubation	0.4116343961237468
extubation	0.4116343961237468
patient	0.3608782174669403
patient	0.3608782174669403
patient	0.3608782174669403
clinicians	0.30236028609127913
clinicians	0.30236028609127913
clinicians	0.3303566088775086
clinicians	0.3303566088775086
clinicians	0.3303566088775086
clinicians	0.3303566088775086
treating	0.32191199257500586
Usual	4.558171980618734
care	1.8284561713000855
care	1.8284561713000855
care	1.8284561713000855
care	1.8284561713000855
selection	0.2904630188260191
selection	0.2904630188260191
postextubation	0.2738257819262904
postextubation	0.2738257819262904
postextubation	0.2738257819262904
decide	0.352884520053803
felt	0.352884520053803
group	0.3397296170094364
group	0.3397296170094364
group	0.3397296170094364
Cointerventions	9.116343961237469
Critical	1.823268792247494
Pain	1.823268792247494
Observation	1.823268792247494
Tool	1.823268792247494
Care	1.4232687922474936
screen	2.3189554174964195
screen	2.3189554174964195
performance	1.6989768456557588
performance	1.6989768456557588
safety	1.6989768456557588
Agitation	1.5193906602062448
Sedation	1.5193906602062448
Richmond	1.5193906602062448
RASS	1.352723993539578
RASS	1.352723993539578
Choice	3.0387813204124896
analgesia	3.0387813204124896
sedation	2.705447987079156
sedation	2.705447987079156
Confusion	2.279085990309367
method	1.882845365129078
CAM-ICU	1.882845365129078
method	1.882845365129078
CAM-ICU	1.882845365129078
mobility	4.558171980618734
Early	4.558171980618734
approach	0.3318118149487415
approach	0.3318118149487415
determines	0.2848857487886709
SATs	0.2848857487886709
extubation	0.25727149757734175
appendix	1.0129271068041632
the online	1.0129271068041632
protocols	0.8368201622795901
supplementary	0.7907048845819409
supplementary	0.7907048845819409
diuretics	0.35062861389374883
clearance	0.35062861389374883
fluids	0.35062861389374883
extubation	0.3166418431721129
extubation	0.3166418431721129
Training	9.116343961237469
protocols	0.28966851771216584
respiratory	0.2891378428168757
respiratory	0.2891378428168757
lecture	0.23375240926249918
support	0.2154779781457692
collection	2.8284561713000853
collection	2.8284561713000853
collection	2.8284561713000853
Data	2.654494519589932
Data	0.6245869457858664
Collected	0.5362555271316158
stored	0.5362555271316158
personnel	0.4774319977198511
prospectively	0.4774319977198511
Characteristics	8.116343961237469
intubation and	0.6511674258026763
admission	0.6511674258026763
race	0.6511674258026763
height	0.6511674258026763
index	0.5797388543741049
Baseline	2.2648052887833687
extubation	1.3721146537458226
extubation	1.3721146537458226
extubation	1.3721146537458226
extubation	1.3721146537458226
6 hours	0.5697714975773418
highest	0.5559643719716771
last	0.38227149757734175
known	0.35355702141251066
rate	0.2832113412822695
96 hours	2.765690730258156
96 hours	2.765690730258156
96 hours	2.765690730258156
Data	2.654494519589932
postextubation	0.42595121632978505
postextubation	0.42595121632978505
postextubation	0.42595121632978505
reintubation	0.2839674775531901
reintubation	0.2839674775531901
Clinical	2.897207933175053
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
days	0.8104909420906686
days	0.8104909420906686
days	0.8104909420906686
days	0.8104909420906686
days	0.8104909420906686
Primary	3.265690730258156
outcome	2.236243885731372
outcome	2.236243885731372
outcome	2.236243885731372
outcome	2.236243885731372
tube	1.2155125281649959
trachea	0.6077562640824979
endotracheal	0.6077562640824979
placement	0.6077562640824979
tracheostomy	0.5410895974158313
reintubation	0.3507833546245289
reintubation	0.3507833546245289
reintubation	0.3507833546245289
reintubation	0.3507833546245289
96 hours	0.3253753800303713
reintubate	0.444699705426218
reintubate	0.444699705426218
team	0.4239816487573249
team	0.4239816487573249
decision	0.3673844614886006
Secondary	3.397207933175053
outcome	2.236243885731372
outcome	2.236243885731372
outcome	2.236243885731372
outcome	2.236243885731372
days	0.6334871731283388
days	0.6334871731283388
days	0.6334871731283388
days	0.6334871731283388
days	0.6334871731283388
Exploratory	3.765690730258156
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
outcomes	2.3284561713000853
All-cause	3.0387813204124896
in-hospital	2.705447987079156
mortality	2.1771271535054373
mortality	2.1771271535054373
mortality	2.1771271535054373
days	1.148195501295114
days	1.148195501295114
days	1.148195501295114
days	1.148195501295114
days	1.148195501295114
Time	2.2648052887833687
enrolment	1.6762937066623762
enrolment	1.6762937066623762
enrolment	1.6762937066623762
reintubation	1.4908292571542479
Indication	1.5193906602062448
laryngeal	1.352723993539578
oedema	1.2552302434193852
oedema	1.2552302434193852
indication	0.9657359777250176
Delirium	2.279085990309367
96 hours	1.382845365129078
96 hours	1.382845365129078
96 hours	1.382845365129078
enrolment	1.2572202799967822
Lowest	1.5193906602062448
SpO2/FiO2	1.5193906602062448
24 hours	1.352723993539578
ratio	1.0193906602062446
ratio	1.0193906602062446
0–6 hours	1.1395429951546836
Highest	1.1395429951546836
6–12 hours	1.1395429951546836
12–24 hours	1.0145429951546836
enrolment	0.6286101399983911
reporting	1.8856374475333901
reporting	1.8856374475333901
Statistical	1.8437938201721038
analysis	1.0779003039585424
analysis	1.0779003039585424
estimation	3.0387813204124896
Sample	2.705447987079156
size	1.73648445520965
size	1.73648445520965
size	1.73648445520965
relative	0.25484766505156115
relative	0.25484766505156115
reintubation	0.2484715428590413
reintubation	0.2484715428590413
reintubation	0.2484715428590413
correlation	0.2597028089833211
correlation	0.2597028089833211
would	0.23523420511436635
intraperiod	0.20957112554568894
intracluster	0.1865826197985625
interim	1.2552302434193852
monitoring	1.1860573268729113
board	1.1324026443916844
safety	0.991069826632526
Data	0.8848315065299773
appointed	0.5362555271316158
18 month	0.5362555271316158
a single-centre	0.5362555271316158
interim	0.4430224388539007
monitoring	0.41860846830808635
principles	3.0387813204124896
Statistical	1.8437938201721038
analysis	1.0779003039585424
analysis	1.0779003039585424
analysis	1.0779003039585424
individual	0.23785675839180623
variables	0.22627649370400682
variables	0.22627649370400682
variables	0.22627649370400682
cluster	0.20465375844949873
Comparison	2.029085990309367
groups	1.2572202799967822
groups	1.2572202799967822
groups	1.2572202799967822
groups	1.2572202799967822
effect	0.39172627628907863
effect	0.39172627628907863
effect	0.39172627628907863
effect	0.39172627628907863
marginal	0.2567516406994197
plots	0.3798476650515612
continuous	0.262874543299161
chronic	0.2414339944312544
Adjusted	0.1899238325257806
splines	0.1899238325257806
Comparison	2.029085990309367
secondary	1.353976060774094
groups	1.2572202799967822
groups	1.2572202799967822
groups	1.2572202799967822
outcome	0.2630875159683967
outcome	0.2630875159683967
outcome	0.2630875159683967
outcome	0.2630875159683967
estimate	0.2561326062947573
Sensitivity	4.558171980618734
analyses	2.397207933175053
analyses	2.397207933175053
analyses	2.397207933175053
analyses	2.397207933175053
primary	0.2306549789385726
primary	0.2306549789385726
secondary	0.222571407250536
patients	0.22110240053715371
patients	0.22110240053715371
Exploratory	3.765690730258156
analyses	2.397207933175053
analyses	2.397207933175053
analyses	2.397207933175053
analyses	2.397207933175053
Time	3.397207933175053
reintubation	2.236243885731372
reintubation	2.236243885731372
reintubation	2.236243885731372
reintubation	2.236243885731372
hazards	0.2532317767010408
96-hour	0.2532317767010408
windows	0.2532317767010408
capturing	0.2532317767010408
window	0.2532317767010408
Effect	2.279085990309367
modification	1.882845365129078
modification	1.882845365129078
subgroup	1.779085990309367
subgroup	1.779085990309367
years	5.656912342600171
years	5.656912342600171
years	5.656912342600171
years	5.656912342600171
Heart	1.5193906602062448
indication	0.9657359777250176
indication	0.9657359777250176
failure	0.9026507071827293
failure	0.9026507071827293
Moderate	3.0387813204124896
severe	3.0387813204124896
COPD	2.038781320412489
COPD	2.038781320412489
COPD	2.038781320412489
extubation >12	3.0387813204124896
APACHE	2.038781320412489
APACHE	2.038781320412489
score	1.7696630130599547
score	1.7696630130599547
index >30 kg/m2	3.0387813204124896
Body	2.705447987079156
mass	2.3721146537458226
SBTs	4.058171980618734
Failure	4.058171980618734
SBTs	4.058171980618734
Duration	1.352723993539578
greater	1.1324026443916844
invasive	0.9026507071827293
mechanical	0.8244031599658592
ventilation	0.7873377564097847
Hernández	1.5193906602062448
Number	1.352723993539578
factors	0.991069826632526
defined	0.7552302434193853
defined	0.7552302434193853
Chronic	1.2552302434193852
exacerbation	1.1324026443916844
exacerbation	1.1324026443916844
exacerbation	1.1324026443916844
COPD	1.0193906602062446
evaluated	0.5038622492478353
‘dose’	0.3963627809233682
correlate	0.3963627809233682
extubation	0.35794295315108415
extubation	0.35794295315108415
Hypoxaemic	3.0387813204124896
failure	1.8053014143654587
failure	1.8053014143654587
failure	1.8053014143654587
respiratory	1.2529306522064614
Hypercapnic	3.0387813204124896
failure	1.8053014143654587
failure	1.8053014143654587
failure	1.8053014143654587
respiratory	1.2529306522064614
Altered	3.0387813204124896
mental	2.3721146537458226
status	1.4719680810321254
status	1.4719680810321254
status	1.4719680810321254
facilitate	4.558171980618734
procedure	2.973209479897578
procedure	2.973209479897578
procedure	2.973209479897578
Other	8.116343961237469
Other	8.116343961237469
Primary	1.632845365129078
indication	1.4486039665875265
indication	1.4486039665875265
mechanical	1.236604739948789
ventilation	1.181006634614677
Duration	1.352723993539578
invasive	0.9026507071827293
enrolment	0.8381468533311881
enrolment	0.8381468533311881
enrolment	0.8381468533311881
pulmonary	0.6123170119234043
fibrosis	0.5697714975773418
fibrosis	0.5697714975773418
lung	0.4707113412822695
disease	0.29525165865366926
Chronic	1.882845365129078
pulmonary	1.632845365129078
disease	1.181006634614677
disease	1.181006634614677
disease	1.181006634614677
APACHE	2.038781320412489
APACHE	2.038781320412489
score	1.7696630130599547
score	1.7696630130599547
score	1.7696630130599547
Respiratory	1.779085990309367
rate	1.132845365129078
rate	1.132845365129078
rate	1.132845365129078
rate	1.132845365129078
Failure	8.116343961237469
index	2.705447987079156
Body	2.705447987079156
index	2.705447987079156
mass	2.3721146537458226
subgroups	0.601210663795368
subgroups	0.601210663795368
interaction	0.44047547850334484
interaction	0.44047547850334484
proceed	0.33764236893472105
Corrections	3.0387813204124896
testing	1.8856374475333901
testing	1.8856374475333901
multiple	1.8437938201721038
single	0.3306131870939172
single	0.3306131870939172
corrections	0.2463876746280397
Editors	0.2463876746280397
Medicines	0.2463876746280397
Handling	3.0387813204124896
missing	2.2648052887833687
missing	2.2648052887833687
data	1.0313253827363378
data	1.0313253827363378
missing	0.29975364116250464
missing	0.29975364116250464
imputed	0.20930423415404317
chronic	0.17042399606912076
96 hours	0.16268769001518565
Trial	3.154494519589932
status	2.207952121548188
status	2.207952121548188
status	2.207952121548188
status	2.207952121548188
31 March	0.40581719806187344
1 October	0.40581719806187344
pragmatic	0.3765690730258156
pragmatic	0.3765690730258156
began	0.3765690730258156
Dissemination	9.116343961237469
Consent	8.116343961237469
initiating	0.676361996769789
Respiratory	0.5930286634364557
undergoing	0.4828679888625088
participating	0.47140936188334753
participating	0.47140936188334753
asserting	0.7596953301031224
inferiority	0.7596953301031224
superiority	0.7596953301031224
There	0.46094845504302595
usual	0.4341211138024125
patient	0.532295370763737
patient	0.532295370763737
patient	0.532295370763737
administer	0.5072714975773418
optimal	0.44477149757734175
activities	0.8368201622795901
record	0.7907048845819409
limited	0.7549350962611229
limited	0.7549350962611229
interaction	0.6607132177550172
evidence-based	0.4341116172017842
advocate	0.4341116172017842
submitted	0.3864925695827366
randomised	0.3388735219636889
meeting	0.3388735219636889
would	0.34108959741583117
risk	0.2744229307491645
risk	0.2744229307491645
risk	0.2744229307491645
risk	0.2744229307491645
Publication	9.116343961237469
journal	1.0129271068041632
scientific	1.0129271068041632
peer-reviewed	1.0129271068041632
conferences	1.0129271068041632
submitted	0.901815995693052
Introduction	6.116343961237468
COVID-19	0.32143936480148394
COVID-19	0.32143936480148394
impacted	0.22370439981731619
spread	0.18052166259876176
PLWH	0.16071968240074197
economic	0.2239917318576958
food	0.20764951817400917
food	0.20764951817400917
food	0.20764951817400917
food	0.20764951817400917
Methods	5.946418959795156
Design	1.5193906602062448
Approval	1.5193906602062448
Setting	1.5193906602062448
Ethical	1.1860573268729113
Participants	0.991069826632526
adherence	0.25190252293471516
adherence	0.25190252293471516
adherence	0.25190252293471516
“BEST”	0.21200799909854579
Registration	0.21200799909854579
transportation	0.2629714604203116
transportation	0.2629714604203116
Uganda	0.24265342458384095
Uganda	0.24265342458384095
Uganda	0.24265342458384095
Uganda	0.33205205469367705
Uganda	0.33205205469367705
Uganda	0.33205205469367705
showing	0.28478399863991116
Mildmay	0.26425899861460744
Data	5.308989039179864
coordinator	0.1981813904616841
clinic	0.17660557314444705
clinic	0.17660557314444705
clinic	0.17660557314444705
telephone	0.1764422600269015
Round	0.4907823421543081
COVID	0.3378300755439472
June	0.2597028089833211
July	0.2597028089833211
lockdown	0.24539117107715405
food	0.3587868257057247
food	0.3587868257057247
food	0.3587868257057247
food	0.3587868257057247
food	0.3587868257057247
pandemic	0.6253585912630573
pandemic	0.6253585912630573
pandemic	0.6253585912630573
pandemic	0.6253585912630573
economic	0.5908187709869658
Quantitative	4.058171980618734
Analysis	3.154494519589932
surveys	0.2854494994865178
surveys	0.2854494994865178
surveys	0.2854494994865178
surveys	0.2854494994865178
fixed-effects	0.22236558797910871
Qualitative	3.558171980618734
Analysis	3.154494519589932
food	0.21755385374480893
food	0.21755385374480893
food	0.21755385374480893
food	0.21755385374480893
food	0.21755385374480893
Results	5.415904243096376
Quantitative	4.058171980618734
Results	2.707952121548188
sample	0.4112726341286013
sample	0.4112726341286013
average	0.3437569189745427
average	0.3437569189745427
11.5 years	0.2399037884536176
COVID	0.46652724717973665
Round	0.3558171980618734
Column	0.32558371290133814
increase	0.3194634122473389
increase	0.3194634122473389
survey	0.5688202541978425
survey	0.5688202541978425
survey	0.5688202541978425
survey	0.5688202541978425
survey	0.5688202541978425
financial	0.4205992692786576
Survey	0.30387813204124897
worse	0.30387813204124897
April-June	0.30387813204124897
reported	0.29439361620642507
Qualitative	3.558171980618734
Results	2.707952121548188
deployed	0.3963627809233682
attention	0.352884520053803
insights	0.352884520053803
coping	0.3274513678485353
driving	0.3274513678485353
Factors	2.279085990309367
Driving	2.279085990309367
Insecurity	1.779085990309367
Food	1.6986039665875265
food	0.2583452013219606
food	0.2583452013219606
food	0.2583452013219606
food	0.2583452013219606
food	0.2583452013219606
food	0.46574909534099934
food	0.46574909534099934
food	0.46574909534099934
food	0.46574909534099934
food	0.46574909534099934
food	0.45864335324841815
food	0.45864335324841815
food	0.45864335324841815
food	0.45864335324841815
food	0.45864335324841815
Adherence	1.823268792247494
Impact	1.823268792247494
Medication	1.823268792247494
Insecurity	1.4232687922474936
Food	1.3588831732700213
medication	0.3294603685758087
take	0.23366626071036534
food	0.2187049323360513
food	0.2187049323360513
food	0.2187049323360513
take	0.3154494519589932
disruptions	0.30387813204124897
disruptions	0.30387813204124897
eaten	0.30387813204124897
initially	0.23721146537458226
Deal	1.823268792247494
Coping	1.823268792247494
Strategies	1.6232687922474938
Insecurity	1.4232687922474936
Food	1.3588831732700213
food	0.29525165865366926
food	0.29525165865366926
food	0.29525165865366926
food	0.29525165865366926
food	0.29525165865366926
foods	0.450907997846526
foods	0.450907997846526
spoilt	0.33764236893472105
cabbages	0.33764236893472105
bought	0.33764236893472105
food	0.35788079836808395
food	0.35788079836808395
food	0.35788079836808395
food	0.35788079836808395
food	0.35788079836808395
food	0.23620132692293538
food	0.23620132692293538
food	0.23620132692293538
food	0.23620132692293538
food	0.23620132692293538
children	0.2646633900403522
children	0.2646633900403522
food	0.2567405727423211
food	0.2567405727423211
food	0.2567405727423211
privacy	0.6077562640824979
IRBs	0.6077562640824979
keeping	0.6077562640824979
Ugandan	0.6077562640824979
rules	0.6077562640824979
